Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
June 26, 2018
Intellectual Property
June 24, 2018
Intellectual Property
June 21, 2018
Intellectual Property
June 20, 2018